We report herein that Bcl11b is a bifunctional transcriptional re

We report herein that Bcl11b is a bifunctional transcriptional regulator, which is required for the correct expression

of approximately 1000 genes in CD4+CD8+CD3lo double-positive (DP) thymocytes. Bcl11b-deficient DP cells displayed a gene expression program associated with mature CD4+CD8− and CD4−CD8+ single-positive (SP) thymocytes, including upregulation of key transcriptional regulators, such as Zbtb7b and Runx3. Bcl11b interacted with regulatory regions of many dysregulated genes, suggesting a direct role in the transcriptional regulation of these genes. However, inappropriate expression of lineage-associated genes did not result in enhanced differentiation, as deletion of Bcl11b Erismodegib in DP cells prevented development of SP thymocytes, and that of canonical NKT cells. These data establish Bcl11b as a crucial transcriptional regulator in thymocytes, in which Bcl11b functions to prevent the premature expression of genes fundamental to the SP and NKT cell differentiation programs. T-cell differentiation is a complex and dynamic process that leads to the production of functionally distinct populations within the thymus – γδ and αβ T-cell subsets, the latter of which include helper CD4+ T cells, cytotoxic CD8+ T cells,

Treg cells, and NKT cells. Hematopoietic progenitor cells enter the thymus as CD4−CD8− double-negative (DN) cells and proceed through successive steps of maturation. DN thymocytes are further Monoiodotyrosine SB203580 solubility dmso divided into at least four developmental stages based on the differential expression of CD44 and CD25: CD44+CD25− (DN1), CD44+CD25+ (DN2), CD44−CD25+ (DN3), and CD44−CD25− (DN4). γδ T cells

differentiate from DN3 thymocytes, following rearrangement of the β, γ, and δ TCR chains. αβ T cells develop from DN4 thymocytes that further differentiate into CD4+CD8+ double-positive (DP) CD3loαβTCRlo thymocytes. Positive selection events between the TCR expressed by DP cells and MHC molecules expressed by thymic stromal cells lead to the appearance of mature CD4+ and CD8+ single-positive (SP) CD3hi/TCRhi thymocytes, and NKT cells, all presumably resulting from large-scale changes in gene expression programs. Transcription factors essential for the αβ T-cell developmental programs have been identified 1–3. In particular, Zbtb7b (also known as ThPok) is required for CD4+ T-cell differentiation 4, 5. Zbtb7b is not expressed in DP thymocytes, but is activated downstream of TCR signaling by TOX 6, 7 and GATA3 8, 9, the latter of which appears to function with Zbtb7b in a positive, self-reinforcing loop that is dependent on the duration and intensity of the TCR signal 10–12. Zbtb7b is believed to function primarily as an enforcement factor to lock down the CD4+ phenotype by repressing CD8+ T-cell-associated genes 13–16.

Related posts:

  1. 1B), it will be important to understand how Bcl11b-mediated Zbtb7
  2. Angiogenesis-focused transcriptional profiling in HT1080 cells A
  3. A master transcriptional regulator of human Th9 cells still await
  4. Figure 3D�CG shows that a nuclear CD44/STAT3 signal was required
  5. Thus far, no proteomics studies, employing large throughput techn
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>